Filtered By:
Vaccination: Hepatitis Vaccine

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 256 results found since Jan 2013.

Acute hepatitis (Non Hepa A-E) of unknown origin among pediatrics
Infez Med. 2022 Sep 1;30(3):353-361. doi: 10.53854/liim-3003-4. eCollection 2022.ABSTRACTSeveral clusters and individual cases of acute hepatitis have been reported in the US, Europe and recently in Asia and Central America since October 2021. A laboratory investigation of the common viral hepatitis agents (HAV, HBV, HCV, HDV and HEV) yielded negative results prompting the use of the term "acute non HepA-E hepatitis" to describe this condition. As of 24 June of 2022, WHO have reported 920 probable cases of severe acute hepatitis of unknown origin among pediatrics in 33 countries in five WHO regions. Since the previous repo...
Source: Infezioni in Medicina - September 23, 2022 Category: Infectious Diseases Authors: Nasim Asadi Faezi Bahareh Mehramouz Sepehr Taghizadeh Pasquale Pagliano Hossein Samadi Kafil Source Type: research

A 54-Year-Old Man With Migratory Pulmonary Consolidation and Progressive Dyspnea
Chest. 2022 Aug;162(2):e85-e88. doi: 10.1016/j.chest.2022.03.004.ABSTRACTA 54-year-old man with chronic hepatitis B was admitted to the hospital with progressive dyspnea on exertion. He reported experiencing intermittent fever, dyspnea on exertion, and relapsing pleuritic chest pain starting 6 months prior, after his first dose of the ChAdOx1 nCoV-19 vaccine. In the past 2 months, he had been admitted to the hospital twice and diagnosed with recurrent pneumonia. Under antibiotic treatment, his dyspnea and low-grade fever demonstrated waxing and waning behaviors. Migratory pulmonary consolidation, which moved from the left ...
Source: Chest - August 8, 2022 Category: Respiratory Medicine Authors: Juei-Yang Ma Cheng-Hao Chuang Source Type: research

PreHevbrio: A New 3-Antigen Hepatitis B Vaccine for Adults
CONCLUSIONS: The 3A-HepB represents another vaccine to prevent hepatitis B in adults. It is safe and immunogenic but is associated with more adverse reactions than 1A-HepB.PMID:35906803 | DOI:10.1177/10600280221114469
Source: The Annals of Pharmacotherapy - July 30, 2022 Category: Drugs & Pharmacology Authors: Allana J Sucher Brandon J Sucher Elias B Chahine Source Type: research

Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum
In this study, a 35-year-old Indian man with an undiagnosed progressive axial spondyloarthropathy (i.e., AS) is reported presenting with acute-onset longitudinally extensive transverse myelitis, a clinical subset of NMOSD. Neuromyelitis optica spectrum disorder (NMOSD), a primary demyelinating disorder of the central nervous system (CNS), is an autoimmune astrocytopathy against foot processes of aquaporin-4 (AQP4) water channels, which manifests with optic neuritis, longitudinally extensive transverse myelitis (LETM), area-postrema syndrome, brainstem syndrome diencephalic syndrome, and cerebral syndrome.1-4 Ankylosing spo...
Source: Herpes - July 22, 2022 Category: Infectious Diseases Authors: Ritwik Ghosh Md Devlina Roy Mois és León-Ruiz Shambaditya Das Souvik Dubey Juli án Benito-León Source Type: research

CDC Endorses Novavax COVID-19 Shot for Adults
U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax—a more traditional kind of vaccine, health officials said Tuesday. Regulators authorized the nation’s first so-called protein vaccine against COVID-19 last week, but the final hurdle was a recommendation from the Centers for Disease Control and Prevention. “If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” Dr. Rochelle Walensky, CDC’s director, said in a s...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Fulminant hepatitis following COVID ‐19 vaccination: A case report
This article presents a young man who developed fulminant hepatitis a few days after vaccination with the first dose of the AstraZeneca COVID-19 vaccine. A 35-year-old man was admitted to our hospital with generalized weakness, abdominal pain, and jaundice. He received the first dose of the AstraZeneca COVID-19 vaccine 8  days earlier. He was admitted to the hospital with a chief complaint of abdominal pain. On admission and because of his high D-dimers, low platelet count, and low Fibrinogen level, vaccine-induced immune thrombosis thrombocytopenia was suspected, which was ruled out later. Then, after a surge in his liv...
Source: Clinical Case Reports - July 19, 2022 Category: General Medicine Authors: Mohammad Barary, Athena Sharifi ‐Razavi, Nasser Rakhshani, Terence T. Sio, Soheil Ebrahimpour, Mana Baziboroun Tags: CASE REPORT Source Type: research

Abstracts of Presentations at the Association of Clinical Scientists 143 < sup > rd < /sup > Meeting Louisville, KY May 11-14,2022
Conclusion: These assays are suitable for routine diagnostic. The UltraFast NextGenPCR is the fastest with average time (30mins), followed by Agilent (2 hrs) and MassArray (6hrs). Upon completion of this activity, participants should be able to examine, measure and compare results from different assays for SARS detection, evaluate and diagnose accurately, as well as being able to plan, organize and recommend a diagnostic procedure for diagnostic laboratory. Key words: SARS-CoV-2, RNA extraction, RT-PCR, limit of detection, quantification cycle, COVID-19, in vitro diagnostic tests, Agilent, Massarray, Ultrafast. [20] From t...
Source: Annals of Clinical and Laboratory Science - July 1, 2022 Category: Laboratory Medicine Source Type: research